Jun 24, 2025 8:00am EDT Ensysce Biosciences Accelerates PF614-MPAR-102 Study with Full Enrollment of Part 2
March 3, 2025 Ensysce Biosciences CEO Dr. Lynn Kirkpatrick and Creighton University's Dr. Neel Pathak Discuss the Opioid Crisis and Next Generation Opioids
December 20, 2023 Navigating the Future of Pain Management: Ensysce Biosciences’ Innovative Approach